Susceptibility of lung cancer patients to COVID-19: A review of the pandemic data from multiple nationalities

dc.creatorLemos, Ana Emília Goulart
dc.creatorSilva, Gabriela Ribeiro
dc.creatorGImba, Etel Rodrigues Pereira
dc.creatorMatos, Aline da Rocha
dc.date2022-02-01T18:35:50Z
dc.date2022-02-01T18:35:50Z
dc.date2021
dc.date.accessioned2023-09-26T20:44:22Z
dc.date.available2023-09-26T20:44:22Z
dc.identifierLEMOS, Ana Emília Goulart et al. Susceptibility of lung cancer patients to COVID-19: A review of the pandemic data from multiple nationalities. Thorac Cancer, v. 12, p. 2637-2647, June 2021.
dc.identifier1759-7714
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/50976
dc.identifier10.1111/1759-7714.14067
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8862986
dc.descriptionSeveral studies have highlighted that cancer patients tend to be more susceptible to develop severe infection and to die from COVID-19. Certain medical conditions such as immunosuppression, presence of comorbidities, and underlying pulmonary damage are possible determinants of disease severity, especially in lung cancer patients. While recent studies have shown that lung cancer is one of the most prevalent tumor types among COVID-19 cancer patients, we still have an incomplete view of how data from several countries work as a whole. The aim of this review was to investigate COVID-19 prevalence in lung cancer patient cohorts and their probability to develop severe illness and death when compared to nonlung cancer patients from multiple nationalities, including countries that have been the epicenters of the pandemic. We also focus on some intrinsic lung cancer features that might influence COVID-19 outcomes. An integrative view of the susceptibility of lung cancer patients might be especially relevant to assist physicians in evaluating the risks of COVID-19 in these patients, and to foster better decisions on treatment delay.
dc.formatapplication/pdf
dc.languageeng
dc.publisherWiley
dc.rightsopen access
dc.subjectCOVID-19
dc.subjectSARS-CoV-2
dc.subjectCâncer de pulmão
dc.subjectMortalidade
dc.subjectSeveridade
dc.subjectCOVID-19
dc.subjectLung cancer
dc.subjectMortality
dc.subjectSARS-CoV-2
dc.subjectSeverity
dc.titleSusceptibility of lung cancer patients to COVID-19: A review of the pandemic data from multiple nationalities
dc.typeArticle


Este ítem pertenece a la siguiente institución